bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 14, 2023
Subcritical
epileptiform
activity
is
associated
with
impaired
cognitive
function
and
commonly
seen
in
patients
Alzheimer's
disease
(AD).
The
anti-convulsant,
levetiracetam
(LEV),
currently
being
evaluated
clinical
trials
for
its
ability
to
reduce
improve
AD.
purpose
of
the
current
study
was
apply
pharmacokinetics
(PK),
network
analysis
medical
imaging,
gene
transcriptomics,
PK/PD
modeling
a
cohort
amyloidogenic
mice
establish
how
LEV
restores
or
drives
alterations
brain
networks
dose-dependent
basis
using
rigorous
preclinical
pipeline
MODEL-AD
Preclinical
Testing
Core.
Journal of Experimental Neurology,
Journal Year:
2024,
Volume and Issue:
5(2), P. 42 - 64
Published: Jan. 1, 2024
Alzheimer’s
Disease
(AD)
and
Disease-Related
Dementia
(ADRD)
are
the
primary
causes
of
dementia
that
has
a
devastating
effect
on
quality
life
is
tremendous
economic
burden
healthcare
system.
The
accumulation
extracellular
beta-amyloid
(Aβ)
plaques
intracellular
hyperphosphorylated
tau-containing
neurofibrillary
tangles
(NFTs)
in
brain
hallmarks
AD.
They
also
thought
to
be
underlying
cause
inflammation,
neurodegeneration,
atrophy,
cognitive
impairments
accompany
discovery
APP,
PS1,
PS2
mutations
increase
Aβ
production
families
with
early
onset
familial
AD
led
development
numerous
transgenic
rodent
models
These
have
provided
new
insight
into
role
AD;
however,
they
do
not
fully
replicate
pathology
patients.
Familial
patients
elevate
represent
only
small
fraction
In
contrast,
those
late-onset
sporadic
constitute
majority
cases.
This
observation,
along
failure
previous
clinical
trials
targeting
or
Tau
modest
success
recent
using
monoclonal
antibodies,
reappraisal
view
sole
factor
pathogenesis
More
studies
established
cerebral
vascular
dysfunction
one
earliest
changes
seen
AD,
67%
candidate
genes
linked
expressed
vasculature.
Thus,
there
an
increasing
appreciation
contribution
National
Institute
Aging
(NIA)
Foundation
recently
prioritized
it
as
focused
research
area.
review
summarizes
strengths
limitations
most
commonly
used
animal
current
views
about
versus
cerebrovascular
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: June 27, 2024
Abstract
Background
Traumatic
brain
injury
(TBI)
is
a
significant
risk
factor
for
Alzheimer’s
disease
(AD),
and
accumulating
evidence
supports
role
adaptive
immune
B
T
cells
in
both
TBI
AD
pathogenesis.
We
previously
identified
cell
major
histocompatibility
complex
class
II
(MHCII)-associated
invariant
chain
peptide
(CLIP)-positive
expansion
after
TBI.
also
showed
that
antagonizing
CLIP
binding
to
the
antigen
presenting
groove
of
MHCII
acutely
reduced
+
splenic
was
neuroprotective.
The
current
study
investigated
chronic
effects
5xFAD
mouse
model,
with
without
Methods
12-week-old
male
wild
type
(WT)
mice
were
administered
either
antagonist
(CAP)
or
vehicle,
once
at
30
min
sham
lateral
fluid
percussion
(FPI).
Analyses
included
flow
cytometric
analysis
dural
meninges
spleen,
histopathological
brain,
magnetic
resonance
diffusion
tensor
imaging,
cerebrovascular
analysis,
assessment
motor
neurobehavioral
function
over
ensuing
6
months.
Results
9-month-old
had
significantly
more
compared
age-matched
WT
mice.
A
one-time
treatment
CAP
this
population
Importantly,
improved
some
immune,
histopathological,
impairments
six
Although
FPI
did
not
further
elevate
meningeal
cells,
it
negate
ability
reduce
3
months
age
exacerbated
aspects
pathology
mice,
including
reducing
hippocampal
neurogenesis,
increasing
plaque
deposition
CA3,
altering
microgliosis,
disrupting
structure.
ameliorated
but
all
these
effects.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 6, 2025
Global
reduction
in
cerebral
blood
flow
(CBF)
is
an
early
pathology
Alzheimer's
disease,
preceding
significant
plaque
accumulation
and
neurological
decline.
Chronic
reduced
CBF
subsequent
tissue
oxygenation
glucose
may
drive
neurodegeneration,
yet
the
underlying
cause
of
globally
remains
unclear.
Using
premortem
delivery
Methoxy-XO4
to
label
Aβ,
arterial
vascular
labeling,
we
assessed
Aβ
burden
on
pial
artery/arteriole
network
aged
male
female
WT
J20
AD
mice.
The
selectively
displayed
extensive
burden.
Pial
collateral
arteriole
vessels,
by-pass
system
that
reroutes
during
occlusion,
enlargement
Despite
this,
was
decreased
by
approximately
15%
12-month
mice
when
compared
littermates.
Significant
meningeal
contribute
restriction
CBF.
Redistribution
through
enlarged
vessels
serve
as
a
compensatory
mechanism
alter
disease
progression
cases
CAA.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(24), P. 17377 - 17377
Published: Dec. 12, 2023
Research
into
Alzheimer's
Disease
(AD)
describes
a
link
between
AD
and
the
resident
immune
cells
of
brain,
microglia.
Further,
this
suspected
is
thought
to
have
underlying
sex
effects,
although
mechanisms
these
effects
are
only
just
beginning
be
understood.
Many
insights
result
policies
put
in
place
by
funding
agencies
such
as
National
Institutes
Health
(NIH)
consider
biological
variable
(SABV)
move
towards
precision
medicine
due
continued
lackluster
therapeutic
options.
The
purpose
review
provide
an
updated
assessment
current
research
that
summarizes
differences
pertaining
microglia
their
varied
responses
AD.
Fluids and Barriers of the CNS,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: March 27, 2024
Abstract
Background
Patients
with
Alzheimer's
disease
(AD)
develop
blood–brain
barrier
dysfunction
to
varying
degrees.
How
aging
impacts
Aβ
pathology,
function,
and
cognitive
decline
in
AD
remains
largely
unknown.
In
this
study,
we
used
5xFAD
mice
investigate
changes
levels,
over
time.
Methods
wild-type
(WT)
were
aged
between
9.5
15.5
months
tested
for
spatial
learning
reference
memory
the
Morris
Water
Maze
(MWM).
After
behavior
testing,
implanted
acute
cranial
windows
intravenously
injected
fluorescent-labeled
dextrans
assess
their
vivo
distribution
brain
by
two-photon
microscopy.
Images
processed
segmented
obtain
intravascular
intensity,
extravascular
vessel
diameters
as
a
measure
of
integrity.
Mice
sacrificed
after
imaging
isolate
plasma
measuring
levels.
The
effect
age
genotype
evaluated
each
assay
using
generalized
or
cumulative-linked
logistic
mixed-level
modeling
model
selection
Akaike
Information
Criterion
(AICc).
Pairwise
comparisons
identify
outcome
differences
two
groups.
Results
displayed
deficits
compared
age-matched
WT
MWM
assay,
which
worsened
age.
Memory
impairment
was
evident
2–threefold
higher
escape
latencies,
twofold
greater
cumulative
distances
until
they
reach
platform,
twice
frequent
use
repetitive
search
strategies
pool
when
mice.
Presence
rd1
allele
performance
at
all
ages
but
did
not
alter
rate
probe
trial
outcomes.
9.5-month-old
15.5-month-old
had
40
42
levels
(
p
<
0.001)
2.5-fold
=
0.007)
Image
analysis
showed
that
intra-
dextran
intensities
significantly
different
9.5-
Conclusion
continue
increased
while
aging.
Given
MP
limitations,
further
investigation
smaller
molecular
weight
markers
combined
advanced
techniques
would
be
needed
reliably
subtle
integrity
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 23, 2023
AbstractBackground:
Reactive
astrocytes
play
important
roles
in
the
development
of
Alzheimer’s
disease
(AD)
and
primary
tauopathies.
Here,
we
aim
to
investigate
relationship
between
reactive
astrocytes,
tau
amyloid
beta,
microgliosis
glucose
metabolism
by
using
multitracer
imaging
widely
used
tauopathy
familial
AD
mouse
models.
Results:
Positron
emission
tomography
(PET)
[18F]SMBT-1
(monoamine
oxidase-B),
[18F]florbetapir
(amyloid-beta),
[18F]PM-PBB3
(tau),
[18F]DPA-714
(translocator
protein)
[18F]fluorodeoxyglucose
(FDG)
was
carried
out
3-
7-month-old
rTg4510
mice,
5×FAD
mice
aged-matched
wild-type
mice.
We
found
increased
regional
[18F]SMBT-1,
uptake,
hypoglucose
brains
with
accumulation
as
well
higher
amyloid-beta
compared
age-matched
Conclusion:
In
summary,
these
findings
provide
in-vivo
evidence
for
microglial
activation,
cerebral
animal
models
AD.
Frontiers in Neuroscience,
Journal Year:
2024,
Volume and Issue:
17
Published: Jan. 24, 2024
Introduction
Subcritical
epileptiform
activity
is
associated
with
impaired
cognitive
function
and
commonly
seen
in
patients
Alzheimer’s
disease
(AD).
The
anti-convulsant,
levetiracetam
(LEV),
currently
being
evaluated
clinical
trials
for
its
ability
to
reduce
improve
AD.
purpose
of
the
current
study
was
apply
pharmacokinetics
(PK),
network
analysis
medical
imaging,
gene
transcriptomics,
PK/PD
modeling
a
cohort
amyloidogenic
mice
establish
how
LEV
restores
or
drives
alterations
brain
networks
dose-dependent
basis
using
rigorous
preclinical
pipeline
MODEL-AD
Preclinical
Testing
Core.
Methods
Chronic
administered
5XFAD
both
sexes
3
months
based
on
allometrically
scaled
dose
levels
from
PK
models.
Data
collection
consisted
multi-modal
approach
utilizing
18
F-FDG
PET/MRI
imaging
analysis,
transcriptomic
analyses,
modeling.
Results
Pharmacokinetics
showed
sex
dependence
C
max
,
CL/F,
AUC
0-∞
simulations
used
estimate
regimens.
dosing
at
10,
30,
56
mg/kg,
specific
regional
differences
uptake,
whole
covariance
measures
such
as
clustering
coefficient,
degree,
density,
connection
strength
(i.e.,
positive
negative).
In
addition,
via
nanoString
changes
expression
pathways
consistent
uptake
changes,
concentration
key
genes,
but
not
Discussion
This
represents
first
report
detailing
relationships
metabolic
resulting
administration
mice.
Overall,
our
results
highlight
non-linear
kinetics
sex,
where
demonstrated
dose-
concentration-dependent
along
cerebral
metabolism,
and/or
homeostatic
mechanisms
relevant
human
AD,
which
aligned
closely
images.
Collectively,
this
show
cases
value
multimodal
connectomic,
transcriptomic,
pharmacokinetic
further
investigate
dependent
studies,
translational
toward
informing
design.